We are live on ! Find out more
CCM

Cullen Capital Management Portfolio holdings

AUM $9.75B
1-Year Est. Return 21.81%
This Fund
S&P 500
This Quarter Est. Return
+2.48%
1 Year Est. Return
+21.81%
3 Year Est. Return
+48.84%
5 Year Est. Return
+62.4%
10 Year Est. Return
+166.06%
AUM
$2.84B
AUM Growth
-$932K
Cap. Flow
-$69.6M
Cap. Flow %
-2.45%
Top 10 Hldgs %
28.85%
Holding
154
New
8
Increased
46
Reduced
58
Closed
14

Top Buys

Rank Stock Value
1
NVS icon
Novartis
NVS
+$7.97M
2
BCE icon
BCE
BCE
+$4.56M
3
CVX icon
Chevron
CVX
+$2.57M
4
GPC icon
Genuine Parts
GPC
+$2.44M
5
VZ icon
Verizon
VZ
+$2.22M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$41.1M
2
UN
Unilever NV New York Registry Shares
UN
+$21.7M
3
PM icon
Philip Morris
PM
+$14.6M
4
MMM icon
3M
MMM
+$12.6M
5
MO icon
Altria Group
MO
+$5.43M

Sector Composition

Rank Sector Weight
1 Financials 15.87%
2 Healthcare 14.29%
3 Industrials 11.23%
4 Technology 10.27%
5 Consumer Staples 9.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JPM icon
1
JPMorgan Chase
JPM
$916B
$90.9M 3.2%
994,420
+10,035
+1% +$866K
NEE icon
2
NextEra Energy
NEE
$184B
$86.7M 3.05%
2,474,500
– –
DD
3
DELISTED
Du Pont De Nemours E I
DD
$85.5M 3%
1,058,950
+15,515
+1% +$1.24M
WELL icon
4
Welltower
WELL
$173B
$85.3M 3%
1,140,000
-31,670
-3% -$2.32M
JNJ icon
5
Johnson & Johnson
JNJ
$640B
$84.2M 2.96%
636,670
-33,172
-5% -$4.23M
MSFT icon
6
Microsoft
MSFT
$2.9T
$79.8M 2.81%
1,158,325
-68,720
-6% -$4.72M
CVX icon
7
Chevron
CVX
$382B
$78.2M 2.75%
749,300
+24,240
+3% +$2.57M
MET icon
8
MetLife
MET
$62.4B
$77.7M 2.73%
1,587,316
+46,316
+3% +$2.15M
CB icon
9
Chubb
CB
$140B
$76.2M 2.68%
523,831
+9,600
+2% +$1.35M
BCE icon
10
BCE
BCE
$20.8B
$76.1M 2.67%
1,689,033
+101,268
+6% +$4.56M
CSCO icon
11
Cisco
CSCO
$443B
$75.2M 2.65%
2,403,725
-107,310
-4% -$3.5M
GPC icon
12
Genuine Parts
GPC
$17.9B
$74.3M 2.61%
801,165
+26,565
+3% +$2.44M
NVS icon
13
Novartis
NVS
$302B
$74.1M 2.61%
990,998
+112,444
+13% +$7.97M
UN
14
DELISTED
Unilever NV New York Registry Shares
UN
$74.1M 2.6%
1,340,444
-402,526
-23% -$21.7M
MRK icon
15
Merck
MRK
$322B
$72.5M 2.55%
1,185,419
+17,376
+1% +$1.06M
MO icon
16
Altria Group
MO
$125B
$71.6M 2.52%
961,650
-74,240
-7% -$5.43M
T icon
17
AT&T
T
$164B
$71.4M 2.51%
2,505,703
-119,127
-5% -$3.51M
GE icon
18
GE Aerospace
GE
$364B
$70.9M 2.49%
547,937
+14,551
+3% +$1.99M
KMB icon
19
Kimberly-Clark
KMB
$37.6B
$70.5M 2.48%
546,150
– –
TRV icon
20
Travelers Companies
TRV
$81.1B
$70.1M 2.46%
553,780
+10,980
+2% +$1.35M
MMM icon
21
3M
MMM
$91.8B
$69.7M 2.45%
400,638
-75,609
-16% -$12.6M
RTN
22
DELISTED
Raytheon Company
RTN
$66.9M 2.35%
414,285
– –
WFC icon
23
Wells Fargo
WFC
$254B
$64.5M 2.27%
1,163,450
+35,900
+3% +$1.92M
DEO icon
24
Diageo
DEO
$49.6B
$61.8M 2.17%
515,905
+455
+0.1% +$54.2K
AZN icon
25
AstraZeneca
AZN
$269B
$60.8M 2.14%
892,433
-44,762
-5% -$2.92M
1
2 3 4

Similar funds

FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
URS
Utah Retirement Systems Salt Lake City, Utah $9.78B AUM 28.72% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
CIM
Centersquare Investment Management Conshohocken, Pennsylvania $9.67B AUM 5.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Cullen Capital Management's Q2 2017 Portfolio in Review

As of Q2 2017, Cullen Capital Management held 154 positions worth $2.84B, down 0.03% from $2.85B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Cullen Capital Management's Q2 2017 filing shows 8 new, 46 increased, 58 reduced and 14 closed positions. Its largest new stake was Gilead Sciences: 8,000 shares worth $566K. The largest sale was ExxonMobil, an estimated $41.1M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Industrials.

  • Cullen Capital Management's largest Q2 2017 buy was Gilead Sciences: 8,000 shares worth $566K.
  • Cullen Capital Management added most to Novartis in Q2 2017, an estimated $7.97M increase.
  • Cullen Capital Management's biggest Q2 2017 reduction was ExxonMobil, cutting an estimated $41.1M.
  • Cullen Capital Management fully exited General Mills in Q2 2017, selling an estimated $783K.
  • Cullen Capital Management's ten largest holdings make up 29% of its $2.84B portfolio in Q2 2017.
  • Cullen Capital Management opened 8 new positions and closed 14 in Q2 2017.
  • Cullen Capital Management's portfolio value fell 0.03% quarter-over-quarter to $2.84B.

Based on Cullen Capital Management's 13F filing for Q2 2017, filed 16 Aug 2017.